What's new

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 25, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Twelfth Industry Standing Group (ISG) meeting, Online, European Medicines Agency...

Next Article

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Va...

Related Posts

Orphan designation: Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues Treatment of familial chylomicronaemia syndrome, 19/07/2021 Positive

Orphan designation: Synthetic double-stranded siRNA oli...

Feb 24, 2025  0

European medicines agencies network strategy (EMANS) to 2028 webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 February 2025, 13:00 (CET) to 13 February 2025, 17:00 (CET)

European medicines agencies network strategy (EMANS) to...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 7, 2025  0